{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:26Z","timestamp":1792787306209,"version":"4.5.0"},"reference-count":68,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"unspecified","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"CZ -DRO","award":["IN 00023001"],"award-info":[{"award-number":["IN 00023001"]}]},{"name":"CZ - DRO","award":["RVO VFN 64165"],"award-info":[{"award-number":["RVO VFN 64165"]}]},{"name":"Czech Ministry of Health","award":["NU20-02-00190"],"award-info":[{"award-number":["NU20-02-00190"]}]},{"name":"Czech Ministry of Health","award":["NV19-02-00118"],"award-info":[{"award-number":["NV19-02-00118"]}]},{"name":"Czech Science Foundation","award":["25-15252S"],"award-info":[{"award-number":["25-15252S"]}],"id":[{"id":"https:\/\/ror.org\/01pv73b02","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Institute for Research of Metabolic and Cardiovascular Diseases","award":["LX22NPO5104"],"award-info":[{"award-number":["LX22NPO5104"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2026,7,12]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to explore the association of long-term left ventricular assist device (LVAD) support with changes in inflammation and cardiac remodelling in subjects with advanced heart failure (HF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A single-centre prospective observational trial was conducted in 16 consecutive subjects with advanced HF who were indicated for implantation of HeartMate 3 LVAD. Blood samples were collected both during the procedure (V1) and 12 months postoperatively (V2) for comprehensive analysis. Additionally, in a subgroup of seven LVAD subjects listed for heart transplantation (HTx), a histological examination was performed on myocardial samples obtained during LVAD implantation and from the explanted heart following HTx.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>LVAD implantation was associated with reductions in brain natriuretic peptide (324.7\u00b147.0 vs 124.6\u00b150.3 pg\/mL) and C reactive protein (15.2\u00b13.8 vs 6.0\u00b11.3 mg\/L) levels. Decreased inflammation markers coincided with reduced levels of lymphocyte- and macrophage-derived cytokines and their stimulating factors. LVAD implantation was associated with modulation of circulating biomarkers related to negative cardiac remodelling processes, including reductions in fibrosis- and remodelling-associated mediators (Extracellular Matrix Metalloproteinase Inducer, fibroblast growth factor (FGF)-2, FGF-19, receptor for advanced glycation endproducts, suppression of tumourigenicity 2, interleukin 27) and angiogenesis-related factors (stromal cell-derived factor-1\u03b1, growth differentiation factor (GDF)-15, somatotropin, vascular endothelial growth factor, angiopoietin 1, hepatocyte growth factor). In parallel, markers of metabolism and systemic catabolic state were significantly modulated, with decreases in GDF-15, somatotropin, trefoil factor 3 and resistin and increases in leptin levels. Histological analysis of myocardial samples available from a subgroup of subjects showed reduced macrophage infiltration following LVAD implantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Long-term LVAD support was associated with improved biochemical and haematological profiles and with coordinated changes in circulating markers of inflammation, metabolism and cardiac remodelling. These exploratory findings provide further insight into the biological changes associated with durable mechanical unloading in subjects with advanced HF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/openhrt-2026-004189","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:06:21Z","timestamp":1786449981000},"page":"e004189","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of a durable left ventricular assist device on inflammation and cardiac remodelling in subjects with advanced heart failure"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-1666","authenticated-orcid":false,"given":"Daniel","family":"Hlavacek","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, IKEM, Prague, Czech Republic"},{"name":"Third Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0174-2933","authenticated-orcid":false,"given":"Anna","family":"Cinkajzlova","sequence":"additional","affiliation":[{"name":"Diabetes Centre, IKEM, Prague, Czech Republic"},{"name":"Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Kollar","sequence":"additional","affiliation":[{"name":"Clinical and Transplant Pathology Centre, IKEM, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbora Judita","family":"Kasperova","sequence":"additional","affiliation":[{"name":"Diabetes Centre, IKEM, Prague, Czech Republic"},{"name":"First Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vojtech","family":"Melenovsky","sequence":"additional","affiliation":[{"name":"Cardiology Department, IKEM, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Mraz","sequence":"additional","affiliation":[{"name":"Diabetes Centre, IKEM, Prague, Czech Republic"},{"name":"Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Haluzik","sequence":"additional","affiliation":[{"name":"Diabetes Centre, IKEM, Prague, Czech Republic"},{"name":"Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital in Prague, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1803-604X","authenticated-orcid":false,"given":"Peter","family":"Ivak","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, IKEM, Prague, Czech Republic"},{"name":"Third Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Stemberkova Hubackova","sequence":"additional","affiliation":[{"name":"Center for Experimental Medicine, IKEM, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"2026091603501963000_13.2.e004189.1","doi-asserted-by":"crossref","first-page":"i38","DOI":"10.1093\/ejcts\/ezz107","article-title":"Does the heart transplant have a future?","volume":"55","author":"Fuchs","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026091603501963000_13.2.e004189.2","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2022-002142","article-title":"Development of algorithms for determining heart failure with reduced and preserved ejection fraction using nationwide electronic healthcare records in the UK","volume":"9","author":"Sundaram","year":"2022","journal-title":"Open Heart"},{"key":"2026091603501963000_13.2.e004189.3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jacbts.2023.12.003","article-title":"Cellular Senescence as a Targetable Risk Factor for Cardiovascular Diseases: Therapeutic Implications: JACC Family Series","volume":"9","author":"Kumar","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"2026091603501963000_13.2.e004189.4","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-21-0159"},{"key":"2026091603501963000_13.2.e004189.5","doi-asserted-by":"publisher","DOI":"10.2174\/1381612824666180110102125"},{"key":"2026091603501963000_13.2.e004189.6","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio0319"},{"key":"2026091603501963000_13.2.e004189.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.10.008"},{"key":"2026091603501963000_13.2.e004189.8","article-title":"Histopathological Analysis of Myocardial Remodeling Following Heart Failure: A Cadaveric Case Report","volume":"17","author":"DeSomma","year":"2025","journal-title":"Cureus"},{"key":"2026091603501963000_13.2.e004189.9","doi-asserted-by":"publisher","DOI":"10.21037\/cdt-20-302"},{"key":"2026091603501963000_13.2.e004189.10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12165217","article-title":"The ABC of Heart Transplantation-Part 1: Indication, Eligibility, Donor Selection, and Surgical Technique","volume":"12","author":"Masarone","year":"2023","journal-title":"J Clin Med"},{"key":"2026091603501963000_13.2.e004189.11","first-page":"490","article-title":"Magnetically Levitated Left Ventricular Assist Device. Reply","volume":"381","author":"Mehra","year":"2019","journal-title":"N Engl J Med"},{"key":"2026091603501963000_13.2.e004189.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.16197"},{"key":"2026091603501963000_13.2.e004189.13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ejhf.1284","article-title":"Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study","volume":"21","author":"Schmitto","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026091603501963000_13.2.e004189.14","unstructured":"World Medical Association Declaration of Helsinki . Ethical principles for medical research involving human subjects. n.d. Available: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects\/"},{"key":"2026091603501963000_13.2.e004189.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(03)01301-1"},{"key":"2026091603501963000_13.2.e004189.16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.028303"},{"key":"2026091603501963000_13.2.e004189.17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/MAT.0b013e3181f127a7","article-title":"B-type natriuretic peptide levels and continuous-flow left ventricular assist devices","volume":"56","author":"Sareyyupoglu","year":"2010","journal-title":"ASAIO J"},{"key":"2026091603501963000_13.2.e004189.18","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-024-12056-5","article-title":"Comprehensive evaluation of serum hepatic proteins in predicting prognosis among cancer patients with cachexia: an observational cohort study","volume":"24","author":"Huang","year":"2024","journal-title":"BMC Cancer"},{"key":"2026091603501963000_13.2.e004189.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.05.040"},{"key":"2026091603501963000_13.2.e004189.20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.114.300507"},{"key":"2026091603501963000_13.2.e004189.21","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvab047"},{"key":"2026091603501963000_13.2.e004189.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2014.06.013"},{"key":"2026091603501963000_13.2.e004189.23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.amjmed.2018.10.006","article-title":"The Association Between Serum Calcium Levels and Short-Term Mortality in Patients with Chronic Heart Failure","volume":"132","author":"Jensen","year":"2019","journal-title":"Am J Med"},{"key":"2026091603501963000_13.2.e004189.24","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.19.2329"},{"key":"2026091603501963000_13.2.e004189.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.08.013"},{"key":"2026091603501963000_13.2.e004189.26","doi-asserted-by":"crossref","first-page":"102163","DOI":"10.1016\/j.arr.2023.102163","article-title":"Pentraxin 3: A promising therapeutic target for cardiovascular diseases","volume":"93","author":"Ye","year":"2024","journal-title":"Ageing Res Rev"},{"key":"2026091603501963000_13.2.e004189.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2022.08.010"},{"key":"2026091603501963000_13.2.e004189.28","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168889","article-title":"GDF15 and Cardiac Cells: Current Concepts and New Insights","volume":"22","author":"Rochette","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026091603501963000_13.2.e004189.29","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1002\/ehf2.12728","article-title":"Growth differentiation factor 15 in adverse cardiac remodelling: from biomarker to causal player","volume":"7","author":"Wesseling","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026091603501963000_13.2.e004189.30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jchf.2024.10.023","article-title":"Growth Differentiation Factor-15 Is Associated With Congestion-Related Anorexia and Weight Loss in Advanced Heart Failure","volume":"13","author":"Monzo","year":"2025","journal-title":"JACC Heart Fail"},{"key":"2026091603501963000_13.2.e004189.31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.508465"},{"key":"2026091603501963000_13.2.e004189.32","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2013.01.742","article-title":"Abnormally high levels of inflammatory markers in recipients of continuous flow left ventricular assist devices","volume":"32","author":"Grosman-Rimon","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2026091603501963000_13.2.e004189.33","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1161\/ATVBAHA.119.311994","article-title":"Growth Factors as Immunotherapeutic Targets in Cardiovascular Disease","volume":"39","author":"Mindur","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026091603501963000_13.2.e004189.34","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.healun.2009.05.041","article-title":"Soluble CD30 levels in recipients undergoing heart transplantation do not predict post-transplant outcome","volume":"28","author":"Ypsilantis","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"2026091603501963000_13.2.e004189.35","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1016\/j.transproceed.2006.10.088","article-title":"Evaluation of soluble CD30 as an immunologic marker in heart transplant recipients","volume":"38","author":"Spiridon","year":"2006","journal-title":"Transplant Proc"},{"key":"2026091603501963000_13.2.e004189.36","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041692","article-title":"Association of Serum BAFF Levels with Cardiovascular Events in ST-Segment Elevation Myocardial Infarction","volume":"12","author":"Wang","year":"2023","journal-title":"J Clin Med"},{"key":"2026091603501963000_13.2.e004189.37","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.115.05627"},{"key":"2026091603501963000_13.2.e004189.38","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.715258","article-title":"Cardiac Fibrosis: Cellular Effectors, Molecular Pathways, and Exosomal Roles","volume":"8","author":"Jiang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2026091603501963000_13.2.e004189.39","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.6.1849"},{"key":"2026091603501963000_13.2.e004189.40","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11247281","article-title":"Factors Associated with RANTES, EMMPIRIN, MMP2 and MMP9, and the Association of These Biomarkers with Cardiovascular Disease in a Multi-Ethnic Population","volume":"11","author":"Wang","year":"2022","journal-title":"J Clin Med"},{"key":"2026091603501963000_13.2.e004189.41","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00346.2008"},{"key":"2026091603501963000_13.2.e004189.42","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-024-03768-4","article-title":"Serum fibroblast growth factor-2 levels complement vital biomarkers for diagnosing heart failure","volume":"24","author":"Yu","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"2026091603501963000_13.2.e004189.43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbrc.2018.05.121","article-title":"Fibroblast growth factor 19 protects the heart from oxidative stress-induced diabetic cardiomyopathy via activation of AMPK\/Nrf2\/HO-1 pathway","volume":"502","author":"Li","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2026091603501963000_13.2.e004189.44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.bbrc.2018.09.046","article-title":"Fibroblast growth factor 19 improves cardiac function and mitochondrial energy homoeostasis in the diabetic heart","volume":"505","author":"Xu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2026091603501963000_13.2.e004189.45","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-012-0089-5"},{"key":"2026091603501963000_13.2.e004189.46","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfq117"},{"key":"2026091603501963000_13.2.e004189.47","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1113\/EP090042","article-title":"AGEs-RAGE axis mediates myocardial fibrosis via activation of cardiac fibroblasts induced by autophagy in heart failure","volume":"107","author":"Liang","year":"2022","journal-title":"Exp Physiol"},{"key":"2026091603501963000_13.2.e004189.48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160555","article-title":"RAGE activation in macrophages and development of experimental diabetic polyneuropathy","volume":"7","author":"Osonoi","year":"2022","journal-title":"JCI Insight"},{"key":"2026091603501963000_13.2.e004189.49","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.2.715"},{"key":"2026091603501963000_13.2.e004189.50","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e17099","article-title":"IL-27 promotes cardiac fibroblast activation and aggravates cardiac remodeling post myocardial infarction","volume":"9","author":"Ma","year":"2023","journal-title":"Heliyon"},{"key":"2026091603501963000_13.2.e004189.51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.hfc.2017.08.005","article-title":"Soluble ST2 in Heart Failure","volume":"14","author":"McCarthy","year":"2018","journal-title":"Heart Fail Clin"},{"key":"2026091603501963000_13.2.e004189.52","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12886","article-title":"Soluble ST2 in end-stage heart failure, before and after support with a left ventricular assist device","volume":"48","author":"Tseng","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"2026091603501963000_13.2.e004189.53","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1018925108"},{"key":"2026091603501963000_13.2.e004189.54","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000158285.57191.60"},{"key":"2026091603501963000_13.2.e004189.55","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2022.10.014"},{"key":"2026091603501963000_13.2.e004189.56","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(01)00663-3"},{"key":"2026091603501963000_13.2.e004189.57","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2019.00914","article-title":"Hepatocyte Growth Factor Regulates Macrophage Transition to the M2 Phenotype and Promotes Murine Skeletal Muscle Regeneration","volume":"10","author":"Choi","year":"2019","journal-title":"Front Physiol"},{"key":"2026091603501963000_13.2.e004189.58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3390\/biomedicines2040247","article-title":"HGF\/Met Axis in Heart Function and Cardioprotection","volume":"2","author":"Gallo","year":"2014","journal-title":"Biomedicines"},{"key":"2026091603501963000_13.2.e004189.59","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201707604"},{"key":"2026091603501963000_13.2.e004189.60","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010290","article-title":"Growth Hormone (GH) and Cardiovascular System","volume":"19","author":"Caicedo","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026091603501963000_13.2.e004189.61","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ehf2.14167","article-title":"Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study","volume":"10","author":"Eidizadeh","year":"2023","journal-title":"ESC Heart Fail"},{"key":"2026091603501963000_13.2.e004189.62","first-page":"A13509","article-title":"Abstract 13509: cardioprotective role of ischemia-induced trefoil factor 3","volume":"124","author":"Liu","year":"2011","journal-title":"Circulation"},{"key":"2026091603501963000_13.2.e004189.63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94170-z","article-title":"Hepatic cell mobilization for protection against ischemic myocardial injury","volume":"11","author":"Liu","year":"2021","journal-title":"Sci Rep"},{"key":"2026091603501963000_13.2.e004189.64","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00354","article-title":"Role of Leptin in Cardiovascular Diseases","volume":"11","author":"Poetsch","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026091603501963000_13.2.e004189.65","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.68","article-title":"Leptin changes differentiation fate and induces senescence in chondrogenic progenitor cells","volume":"7","author":"Zhao","year":"2016","journal-title":"Cell Death Dis"},{"key":"2026091603501963000_13.2.e004189.66","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1302\/2046-3758.89.BJR-2018-0325.R2","article-title":"Activation of the leptin pathway by high expression of the long form of the leptin receptor (Ob-Rb) accelerates chondrocyte senescence in osteoarthritis","volume":"8","author":"Zhao","year":"2019","journal-title":"Bone Joint Res"},{"key":"2026091603501963000_13.2.e004189.67","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1002\/ehf2.14064","article-title":"Resistin and risks of incident heart failure subtypes and cardiac fibrosis: the Multi-Ethnic Study of Atherosclerosis","volume":"9","author":"Cai","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026091603501963000_13.2.e004189.68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25010288","article-title":"Cellular and Molecular Mechanisms Activated by a Left Ventricular Assist Device","volume":"25","author":"Galeone","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2026-004189","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:50:41Z","timestamp":1789555841000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2026-004189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":68,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,8,11]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/openhrt-2026-004189"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2026-004189","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}